Baird Reiterates an 'Outperform' on Celgene (CELG); Buyback Will Help Investors Get In Early
Tweet Send to a Friend
Baird reiterates an 'Outperform' on Celgene (NASDAQ: CELG) price target of $81.00.
Analyst, Christopher Raymond, said, "Not only do ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Analyst, Christopher Raymond, said, "Not only do ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
